Rational Study Endpoint(s) for Preoperative Trials in Pancreatic Cancer: Pathologic Response Rate, Margin Negative Resection, Overall Survival or ‘All of the Above’? | Zendy

AI Assistant Blog Pricing

Rational Study Endpoint(s) for Preoperative Trials in Pancreatic Cancer: Pathologic Response Rate, Margin Negative Resection, Overall Survival or ‘All of the Above’?

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.